Slate: The Vioxx war

This Slate article about the kerfluffle between the Wall Street Journal and the New England Journal of Medicine over the Vioxx crisis is worth reading for its exegesis of the research that identified the problem with Vioxx (and other COX-2 inhibitors) in the first place.

See previous entry: Vioxx study withheld data: medical journal.